European Commission

NANJING, China — September 28, 2026 Leads Biolabs announced that opamtistomig (LBL-024), its investigational PD-L1/4-1BB bispecific antibody, has received...

Cambridge, United Kingdom, September 23, 2026 AstraZeneca has announced that Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has received European Commission...

Basel, Switzerland, September 21, 2026 Roche has announced that the European Commission has approved Susvimo® (ranibizumab 100 mg/mL) for...

REDWOOD CITY, Calif. — September 18, 2026 Corcept Therapeutics announced that the European Medicines Agency’s Committee for Medicinal Products...

TOKYO — September 18, 2026 Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency’s Committee for Medicinal Products...

Chengdu, China, September 22, 2026 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced that multiple Phase 3 studies of sacituzumab tirumotecan...

North Chicago, Illinois, U.S., September 22, 2026 AbbVie has announced that the European Commission has approved RINVOQ® (upadacitinib) for...

Beerse, Belgium, September 21, 2026 Johnson & Johnson has reached a major European regulatory milestone with the European Commission’s...

RAHWAY, N.J. — September 18, 2026 Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human...

NANJING, China and BASILDON, UK — September 18, 2026 IMPACT Therapeutics and Pharmanovia announced that the Committee for Medicinal...